Request for Trademark 'Bacchus-S' Retracted

Published: 2005-01-04 06:58:00

Updated: 2005-01-04 06:58:00

Dong-A Pharmaceutical announced on December 30th that it has officially retracted its request to receive an approval from the Korea Food and Drug Administration (KFDA) on the possible use of a trademark 'Bacchus-S', a drink-type quasi medicine.

The above decision by Dong-A is thought to be bas...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK